Journal Title：Expert Review Of Clinical Immunology

Expert Review of Clinical Immunology (ISSN 1744-666X) provides expert analysis and commentary regarding the performance of new therapeutic and diagnostic modalities in clinical immunology. Members of the International Editorial Advisory Panel of Expert Review of Clinical Immunology are the forefront of their area of expertise. This panel works with our dedicated editorial team to identify the most important and topical review themes and the corresponding expert(s) most appropriate to provide commentary and analysis. All articles are subject to rigorous peer-review, and the finished reviews provide an essential contribution to decision-making in clinical immunology.

Articles focus on the following key areas:

? Therapeutic overviews of specific immunologic disorders highlighting optimal therapy and prospects for new medicines

? Performance and benefits of newly approved therapeutic agents

? New diagnostic approaches

? Screening and patient stratification

? Pharmacoeconomic studies

? New therapeutic indications for existing therapies

? Adverse effects, occurrence and reduction

? Prospects for medicines in late-stage trials approaching regulatory approval

? Novel treatment strategies

? Epidemiological studies

? Commentary and comparison of treatment guidelines

Topics include infection and immunity, inflammation, host defense mechanisms, congenital and acquired immunodeficiencies, anaphylaxis and allergy, systemic immune diseases, organ-specific inflammatory diseases, transplantation immunology, endocrinology and diabetes, cancer immunology, neuroimmunology and hematological diseases.

《臨床免疫學專家評論》（ISSN 1744-666X）提供有關臨床免疫學中新治療和診斷方式表現的專家分析和評論?！杜R床免疫學專家評論》國際編輯顧問小組的成員是各自專業(yè)領域的領軍人物。該小組與我們專門的編輯團隊合作，確定最重要的熱門評論主題以及最適合提供評論和分析的相應專家。所有文章均經過嚴格的同行評審，完成的評審結果將為臨床免疫學決策提供重要貢獻。

文章重點關注以下關鍵領域：

? 特定免疫疾病的治療概述，重點介紹最佳治療方法和新藥前景

? 新批準治療藥物的性能和益處

? 新的診斷方法

? 篩查和患者分層

? 藥物經濟學研究

? 現有療法的新治療指征

? 不良反應、發(fā)生和減少

? 即將獲得監(jiān)管部門批準的處于后期試驗階段的藥物前景

? 新的治療策略

? 流行病學研究

? 治療指南的評論和比較

主題包括感染和免疫、炎癥、宿主防御機制、先天性和獲得性免疫缺陷、過敏反應和變態(tài)反應、全身免疫疾病、器官特異性炎癥疾病、移植免疫學、內分泌學和糖尿病、癌癥免疫學、神經免疫學和血液學疾病。

Expert Review Of Clinical Immunology創(chuàng)刊于2005年，由Taylor and Francis Ltd.出版商出版，收稿方向涵蓋IMMUNOLOGY全領域，此刊是中等級別的SCI期刊，所以過審相對來講不是特別難，但是該刊專業(yè)認可度不錯，仍然是一本值得選擇的SCI期刊 。平均審稿速度 較慢,6-12周 ，影響因子指數3.9，該期刊近期沒有被列入國際期刊預警名單，廣大學者值得一試。